Natural musk and bezoar Chinese patent medicine are expected to adjust prices in the market

The Beijing Municipal Development and Reform Commission yesterday forwarded the notice of the national development and Reform Commission on "adjusting the list of priced drugs" In the future, Chinese patent medicines marked with "natural musk" and "natural bezoar" will no longer be priced by the government, but will be regulated by the market According to the new list of priced drugs, the number of drugs priced by the national development and Reform Commission will be adjusted from 1561 in 2005 to 1917, and another 565 drugs will be included in the pricing scope of the price departments of all provinces, autonomous regions and municipalities directly under the central government The new list of priced drugs has been in effect since April 1 In addition, the new list of priced drugs also stipulates that Angong Niuhuang Pill marked with "natural musk" and other Chinese patent medicines with "natural musk" and "natural Niuhuang" as medicine, which are not included in the price list of price departments of all provinces, autonomous regions and municipalities directly under the central government, will be subject to market price adjustment According to the data, only a small number of Chinese patent medicines such as Pianzihuang are currently carrying out market price adjustment in China, and the price increase of Chinese herbal medicines has brought great cost pressure to many companies that use natural Chinese herbal medicines as raw materials to produce Chinese patent medicines In addition, according to the requirements of Beijing Municipal Development and Reform Commission, the new varieties transferred into the reimbursement scope of medical insurance will be automatically included in the list of drugs priced in this Municipality For drugs that are not included in the pricing scope of the national development and Reform Commission, the market will adjust the price, and the enterprise will make its own price.